EPA Rejects Criticisms Of BaP IRIS Assessment's Stringency In New Draft

EPA has issued an updated version of its draft assessment of the human health risks of benzo(a)pyrene (BaP) in which the agency rejects industry criticisms that the earlier 2013 version of the study was too strict, and while EPA says it has reviewed several studies industry cited to boost its claims the risk numbers appear largely unchanged. The BaP assessment , which EPA is preparing for peer review by its Chemical Assessment Advisory Committee (CAAC), for the first time presents...